<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, while waiting for an effective and safe vaccine the main task is to understand the individual virus susceptibility/receptivity together with the repurposing of already available pharmacological compounds, such as selected anti-inflammatory, anti-malaria, and anticoagulant drugs as well as reconsidering RAS-antagonists in selected patients to achieve efficient and personalized targeted therapies.</p>
